| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,051,064 | 1,090,399 | 1,024,726 | 1,168,957 | | Cost of Revenue | 665,859 | 704,078 | 656,953 | 757,385 | | | Gross Profit | 385,205 | 386,321 | 367,773 | 411,572 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 235,716 | 227,568 | 220,636 | 255,701 | | Non Recurring | (11,718) |
-
|
-
| 13,873 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 161,207 | 158,753 | 147,137 | 141,998 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,558 | 387 | (8,220) | 13,578 | | Earnings Before Interest And Taxes | 168,765 | 159,140 | 138,917 | 172,539 | | Interest Expense | 10,119 | 9,931 | 10,109 | 12,598 | | Income Before Tax | 158,646 | 149,209 | 128,808 | 159,941 | | Income Tax Expense | 42,006 | 40,604 | 35,983 | 45,509 | | Minority Interest | (601) | 520 | (520) |
-
| | | | Net Income From Continuing Ops | 116,039 | 109,125 | 92,305 | 114,432 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 116,039 | 109,125 | 92,305 | 114,432 | | Preferred Stock And Other Adjustments | 905 | (905) |
-
|
-
| | | Net Income Applicable To Common Shares | $116,944 | $108,220 | $92,305 | $114,432 |
|
1.00% Nasdaq 0.00%
Income Statement
